Strong association between shiga toxin-producing Escherichia coli O157 and virulence genes stx2 and eae as possible explanation for predominance of serogroup O157 in patients with haemolytic uraemic syndrome

被引:72
作者
Werber, D
Fruth, A
Buchholz, U
Prager, R
Kramer, MH
Ammon, A
Tschäpe, H
机构
[1] Robert Koch Inst, Dept Infect Dis Epidemiol, D-13353 Berlin, Germany
[2] Robert Koch Inst, Natl Reference Ctr Salmonella & Other Bacterial E, D-38855 Wernigerode, Germany
关键词
D O I
10.1007/s10096-003-1025-0
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The aim of this study was to investigate the association between Shiga toxin-producing Escherichia coli (STEC) O157 and the simultaneous presence of the virulence genes stx(2) and eae in STEC from patients with gastroenteritis. In Germany, the proportion of serogroup O157 is substantially higher among STEC isolates from patients with haemolytic uraemic syndrome (HUS) than among STEC isolates from patients with gastroenteritis. The reason for this is unknown. Independent of serogroup, the virulence genes stx(2) and eae have been associated with severe disease. Data collected in 2000-2001 from a Germany-wide laboratory-based surveillance system for STEC-associated gastroenteritis in patients <15 years were analysed. Overall, 18% of the STEC isolates belonged to serogroup O157. Compared with non-O157 strains, O157 isolates were strongly associated with the simultaneous presence of both an stx(2) gene and the eae gene (OR, 76; 95%CI, 27-230). Within the subset of STEC isolates that carried both virulence genes, 60% belonged to serogroup O157, a proportion similar to that found in STEC isolates from pediatric patients with HUS in Germany and Austria (67%, P=0.35). These data suggest that the more frequent carriage of both virulence genes, i.e. stx(2) and eae, forms the basis of why STEC O157 predominates in patients with HUS.
引用
收藏
页码:726 / 730
页数:5
相关论文
共 24 条
[1]  
ACHESON DW, 1998, 98 GEN M AM SOC MICR
[2]   The United States national prospective hemolytic uremic syndrome study: Microbiologic, serologic, clinical, and epidemiologic findings [J].
Banatvala, N ;
Griffin, PM ;
Greene, KD ;
Barrett, TJ ;
Bibb, WF ;
Green, JH ;
Wells, JG .
JOURNAL OF INFECTIOUS DISEASES, 2001, 183 (07) :1063-1070
[3]   EVIDENCE FOR PARTICIPATION OF THE MACROPHAGE IN SHIGA-LIKE TOXIN-II-INDUCED LETHALITY IN MICE [J].
BARRETT, TJ ;
POTTER, ME ;
STROCKBINE, NA .
MICROBIAL PATHOGENESIS, 1990, 9 (02) :95-103
[4]   VIRULENCE MARKERS OF SHIGA-LIKE TOXIN-PRODUCING ESCHERICHIA-COLI STRAINS ORIGINATING FROM HEALTHY DOMESTIC-ANIMALS OF DIFFERENT SPECIES [J].
BEUTIN, L ;
GEIER, D ;
ZIMMERMANN, S ;
KARCH, H .
JOURNAL OF CLINICAL MICROBIOLOGY, 1995, 33 (03) :631-635
[5]   Associations between virulence factors of Shiga toxin-producing Escherichia coli and disease in humans [J].
Boerlin, P ;
McEwen, SA ;
Boerlin-Petzold, F ;
Wilson, JB ;
Johnson, RP ;
Gyles, CL .
JOURNAL OF CLINICAL MICROBIOLOGY, 1999, 37 (03) :497-503
[6]   SIMULTANEOUS IDENTIFICATION OF STRAINS OF ESCHERICHIA-COLI SEROTYPE O157-H7 AND THEIR SHIGA-LIKE TOXIN TYPE BY MISMATCH AMPLIFICATION MUTATION ASSAY-MULTIPLEX PCR [J].
CEBULA, TA ;
PAYNE, WL ;
FENG, P .
JOURNAL OF CLINICAL MICROBIOLOGY, 1995, 33 (01) :248-250
[7]   Identification of Escherichia coli O-serogroups by restriction of the amplified O-antigen gene cluster (rfb-RFLP) [J].
Coimbra, RS ;
Grimont, F ;
Lenormand, P ;
Burguière, P ;
Beutin, L ;
Grimont, PAD .
RESEARCH IN MICROBIOLOGY, 2000, 151 (08) :639-654
[8]   Escherichia coli O157:H7 infections:: Discordance between filterable fecal Shiga toxin and disease outcome [J].
Cornick, NA ;
Jelacic, S ;
Ciol, MA ;
Tarr, PI .
JOURNAL OF INFECTIOUS DISEASES, 2002, 186 (01) :57-63
[9]   Clinical Escherichia coli strains carrying stx genes:: stx variants and stx-positive virulence profiles [J].
Eklund, M ;
Leino, K ;
Siitonen, A .
JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (12) :4585-4593
[10]   Prevalence of non-O157:H7 shiga toxin-producing Escherichia coli in diarrheal stool samples from Nebraska [J].
Fey, PD ;
Wickert, RS ;
Rupp, ME ;
Safranek, TJ ;
Hinrichs, SH .
EMERGING INFECTIOUS DISEASES, 2000, 6 (05) :530-533